SDS

SDS – Dry Up Pellets Mole & Gopher Killer Page 2
SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substance/Mixture: Mixture
Chemical Name
CAS Number
WT %
Diphacinone
(2-Diphenylacetyl-1,3-Inandione)
82-66-6
0.005
*Other ingredients
Not applicable
99.995
*the exact percentage (concentration) has been withheld as a trade secret
The remaining components of this product are non-hazardous or are in small enough quantities as to not to meet thresholds for
disclosure. These components contain no substances or impurities which influence the classification of this product.
SECTION 4. FIRST AID MEASURES
Emergency Overview: This material may reduce the clotting ability of the blood and cause bleeding. Symptoms of toxicity
include lethargy, loss of appetite, reduced clotting ability of blood and bleeding. Have the product label with you when
obtaining treatment advice.
EYES: Hold eye open and rinse slowly and gently with water for 15-20 minutes. Remove contact lenses, if present, after the
first 5 minutes, then continue rinsing eye. Call a poison control center or doctor for treatment advice.
SKIN: Rinse skin with plenty of water. Wash clothing before reuse. Call a poison control center or doctor for treatment advice.
INHALATION: No anticipated need for first aid measures.
INGESTION: Call a poison control center or doctor for treatment advice. Have person sip a glass of water if able to swallow.
Do not induce vomiting unless told to do so by a poison control center or a doctor. Never give anything by mouth to an
unconscious person.
NOTE TO PHYSICIAN OR VETERINARIANS:
This product contains anticoagulants with an effect similar to warfarin in that they act by interfering with the synthesis of
prothrombin. The specific measure is the prothrombin time. Note this may not become prolonged until 12-18 hours after
ingestion. The specific antidote is Vitamin K1 (Phytomenandione BP).
Antidote must be administered under medical supervision. Initially, antidote should be given by injection (10-20 mg, or 0.25
mg/kg for children, by slow intravenous infusion at a rate of 1 mg/minute. In severe cases the use of fresh frozen plasma may
be required). Maintenance treatment is given orally (40 mg/day in divided doses for adults; up to 20 mg/day in divided doses for
children). The prothrombin time and the hemoglobin should be monitored. Patients should be kept under medical supervision
until the prothrombin time has been normal for 3 consecutive days. Oral treatment may need to be continued for several weeks.
(20 mg/day in divided doses for adults, and up to 20 mg/day in divided doses for children). (For animal cases the dose is 2-5
mg/kg).
SECTION 5. FIRE FIGHTING MEASURES
EXTINGUISHING MEDIA: Use any means suitable for extinguishing surrounding fire.
SPECIFIC HAZARDS: Avoid generating dusts. Keep out of waterways. Under conditions of fire this material may produce:
Carbon oxides (CO, CO2). Contain runoff.
SPECIAL PROTECTIVE EQUIPMENT: Safety glasses, gloves.